These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 21783364)
1. Synthesis and biological evaluation of substituted 4-arylthiazol-2-amino derivatives as potent growth inhibitors of replicating Mycobacterium tuberculosis H₃₇Rv. Roy KK; Singh S; Sharma SK; Srivastava R; Chaturvedi V; Saxena AK Bioorg Med Chem Lett; 2011 Sep; 21(18):5589-93. PubMed ID: 21783364 [TBL] [Abstract][Full Text] [Related]
2. Development of 5-nitrothiazole derivatives: identification of leads against both replicative and latent Mycobacterium tuberculosis. Jeankumar VU; Chandran M; Samala G; Alvala M; Koushik PV; Yogeeswari P; Salina EG; Sriram D Bioorg Med Chem Lett; 2012 Dec; 22(24):7414-7. PubMed ID: 23137434 [TBL] [Abstract][Full Text] [Related]
3. A regio- and stereoselective 1,3-dipolar cycloaddition for the synthesis of new-fangled dispiropyrrolothiazoles as antimycobacterial agents. Almansour AI; Ali S; Ali MA; Ismail R; Choon TS; Sellappan V; Elumalai KK; Pandian S Bioorg Med Chem Lett; 2012 Dec; 22(24):7418-21. PubMed ID: 23122863 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of some novel 2-substituted-5-[isopropylthiazole] clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents. Suresh Kumar GV; Rajendraprasad Y; Mallikarjuna BP; Chandrashekar SM; Kistayya C Eur J Med Chem; 2010 May; 45(5):2063-74. PubMed ID: 20149496 [TBL] [Abstract][Full Text] [Related]
6. 2-(2-Hydrazinyl)thiazole derivatives: design, synthesis and in vitro antimycobacterial studies. Makam P; Kankanala R; Prakash A; Kannan T Eur J Med Chem; 2013 Nov; 69():564-76. PubMed ID: 24095750 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of novel 6, 7-dimethoxy-3-(4-pyridyl)-2,3,3a,4-tetrahydroindeno[1,2-c]pyrazol-2-yl-4-substituted phenylmethanone/ethanone derivatives. Ali MA; Ismail R; Choon TS; Elumalai M; Kumar S; Osman H; Govidasamy J; Yadav R; Yadav G; Kour R; Vyas S J Enzyme Inhib Med Chem; 2012 Feb; 27(1):155-9. PubMed ID: 21635209 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and antimycobacterial evaluation of various 6-substituted pyrazolo[3,4-d]pyrimidine derivatives. Trivedi A; Vaghasiya S; Dholariya B; Dodiya D; Shah V J Enzyme Inhib Med Chem; 2010 Dec; 25(6):893-9. PubMed ID: 21054238 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of α-ketotriazoles and α,β-diketotriazoles as inhibitors of Mycobacterium tuberculosis. Menendez C; Rodriguez F; Ribeiro AL; Zara F; Frongia C; Lobjois V; Saffon N; Pasca MR; Lherbet C; Baltas M Eur J Med Chem; 2013 Nov; 69():167-73. PubMed ID: 24016834 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and antimycobacterial activities of some new thiazolylhydrazone derivatives. Ozadali K; Tan OU; Yogeeswari P; Dharmarajan S; Balkan A Bioorg Med Chem Lett; 2014 Apr; 24(7):1695-7. PubMed ID: 24631185 [TBL] [Abstract][Full Text] [Related]
11. New class of methyl tetrazole based hybrid of (Z)-5-benzylidene-2-(piperazin-1-yl)thiazol-4(%H)-one as potent antitubercular agents. Chauhan K; Sharma M; Trivedi P; Chaturvedi V; Chauhan PM Bioorg Med Chem Lett; 2014 Sep; 24(17):4166-70. PubMed ID: 25127167 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2. Lu X; Liu X; Wan B; Franzblau SG; Chen L; Zhou C; You Q Eur J Med Chem; 2012 Mar; 49():164-71. PubMed ID: 22264895 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors. Samala G; Devi PB; Saxena S; Meda N; Yogeeswari P; Sriram D Bioorg Med Chem; 2016 Mar; 24(6):1298-307. PubMed ID: 26867485 [TBL] [Abstract][Full Text] [Related]
14. A new synthetic access to furo[3,2-f]chromene analogues of an antimycobacterial. Alvey L; Prado S; Huteau V; Saint-Joanis B; Michel S; Koch M; Cole ST; Tillequin F; Janin YL Bioorg Med Chem; 2008 Sep; 16(17):8264-72. PubMed ID: 18752967 [TBL] [Abstract][Full Text] [Related]
15. Diversity oriented design of various hydrazides and their in vitro evaluation against Mycobacterium tuberculosis H37Rv strains. Manvar A; Bavishi A; Radadiya A; Patel J; Vora V; Dodia N; Rawal K; Shah A Bioorg Med Chem Lett; 2011 Aug; 21(16):4728-31. PubMed ID: 21752642 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antimicrobial activity of N¹-benzyl or N¹-benzyloxy-1,6-dihydro-1,3,5-triazine-2,4-diamines. Ma X; Tan ST; Khoo CL; Sim HM; Chan LW; Chui WK Bioorg Med Chem Lett; 2011 Sep; 21(18):5428-31. PubMed ID: 21788136 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, structure-activity relationship and in vitro anti-mycobacterial evaluation of 13-n-octylberberine derivatives. Liu YX; Xiao CL; Wang YX; Li YH; Yang YH; Li YB; Bi CW; Gao LM; Jiang JD; Song DQ Eur J Med Chem; 2012 Jun; 52():151-8. PubMed ID: 22503208 [TBL] [Abstract][Full Text] [Related]
18. Ring-substituted quinolines. Part 2: Synthesis and antimycobacterial activities of ring-substituted quinolinecarbohydrazide and ring-substituted quinolinecarboxamide analogues. Monga V; Nayyar A; Vaitilingam B; Palde PB; Jhamb SS; Kaur S; Singh PP; Jain R Bioorg Med Chem; 2004 Dec; 12(24):6465-72. PubMed ID: 15556764 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of some novel N-aryl-1,4-dihydropyridines as potential antitubercular agents. Trivedi AR; Dodiya DK; Dholariya BH; Kataria VB; Bhuva VR; Shah VH Bioorg Med Chem Lett; 2011 Sep; 21(18):5181-3. PubMed ID: 21824772 [TBL] [Abstract][Full Text] [Related]